Advanced search
Publication Cover
Xenobiotica
the fate of foreign compounds in biological systems
Volume 50, 2020 - Issue 4
Submit an article Journal homepage
272
Views
5
CrossRef citations to date
0
Altmetric
Pharmacogenetics

Pharmacogenomics analysis in Chinese pediatric liver transplantation patients with renal toxicity induced by tacrolimus

Dongdong WangDepartment of Pharmacy, Children’s Hospital of Fudan University, Shanghai, China; ORCID Iconhttp://orcid.org/0000-0002-4019-5530View further author information
ORCID Icon,
Xiao ChenDepartment of Pharmacy, Children’s Hospital of Fudan University, Shanghai, China; View further author information
,
Meng FuDepartment of Pharmacy, Children’s Hospital of Fudan University, Shanghai, China; View further author information
,
Hong XuDepartment of Nephrology, Children’s Hospital of Fudan University, Shanghai, ChinaCorrespondence[email protected]
View further author information
&
Zhiping LiDepartment of Pharmacy, Children’s Hospital of Fudan University, Shanghai, China; Correspondence[email protected]
ORCID Iconhttp://orcid.org/0000-0001-6194-023XView further author information
ORCID Icon
Pages 488-493 | Received 10 Jun 2019, Accepted 02 Aug 2019, Published online: 14 Aug 2019

References

  • Beysens AJ, Wijnen RM, Beuman GH, et al. (1991). FK 506: monitoring in plasma or in whole blood? Transplant Proc 23:2745–7.
  • Dai Y, Hebert MF, Isoherranen N, et al. (2006). Effect of CYP3A5 polymorphism on tacrolimus metabolic clearance in vitro. Drug Metab Dispos 34:836–47.
  • Dong QE, Fu R, Liu CY, et al. (2013). [Inhibitory effects of tacrolimus on effector T cells from patients with severe aplastic anemia]. Zhonghua Yi Xue Za Zhi 93:1541–5.
  • Fukudo M, Yano I, Masuda S, et al. (2006). Population pharmacokinetic and pharmacogenomic analysis of tacrolimus in pediatric living-donor liver transplant recipients. Clin Pharmacol Ther 80:331–45.
  • Fukudo M, Yano I, Yoshimura A, et al. (2008). Impact of MDR1 and CYP3A5 on the oral clearance of tacrolimus and tacrolimus-related renal dysfunction in adult living-donor liver transplant patients. Pharmacogenet Genomics 18:413–23.
  • Hawwa AF, McElnay JC. (2011). Impact of ATP-binding cassette, subfamily B, member 1 pharmacogenetics on tacrolimus-associated nephrotoxicity and dosage requirements in paediatric patients with liver transplant. Expert Opin Drug Saf 10:9–22.
  • Hawwa AF, McKiernan PJ, Shields M, et al. (2009). Influence of ABCB1 polymorphisms and haplotypes on tacrolimus nephrotoxicity and dosage requirements in children with liver transplant. Br J Clin Pharmacol 68:413–21.
  • Ho S, Clipstone N, Timmermann L, et al. (1996). The mechanism of action of cyclosporin A and FK506. Clin Immunol Immunopathol 80:S40–S45.
  • Ichikawa K, Konta T, Emi M, et al. (2009). Genetic polymorphisms of paraoxonase-1 are associated with chronic kidney disease in Japanese women. Kidney Int 76:183–9.
  • Jiang X, Konkalmatt P, Yang Y, et al. (2014). Single-nucleotide polymorphisms of the dopamine D2 receptor increase inflammation and fibrosis in human renal proximal tubule cells. Hypertension 63:e74–80.
  • Jusko WJ, Thomson AW, Fung J, et al. (1995). Consensus document: therapeutic monitoring of tacrolimus (FK-506). Ther Drug Monit 17:606–14.
  • Maguire O, Tornatore KM, O'Loughlin KL, et al. (2013). Nuclear translocation of nuclear factor of activated T cells (NFAT) as a quantitative pharmacodynamic parameter for tacrolimus. Cytometry A 83:1096–104.
  • Masuda S, Inui K. (2006). An up-date review on individualized dosage adjustment of calcineurin inhibitors in organ transplant patients. Pharmacol Ther 112:184–98.
  • Morris MC, Allanby CW, Toseland P, et al. (1982). Evaluation of a height/plasma creatinine formula in the measurement of glomerular filtration rate. Arch Dis Child 57:611–5.
  • Passey C, Birnbaum AK, Brundage RC, et al. (2011). Dosing equation for tacrolimus using genetic variants and clinical factors. Br J Clin Pharmacol 72:948–57.
  • Seaberg EC, Belle SH, Beringer KC, et al. (1998). Liver transplantation in the United States from 1987–1998: updated results from the Pitt-UNOS Liver Transplant Registry. Clin Transpl 17–37.
  • Staatz CE, Tett SE. (2004). Clinical pharmacokinetics and pharmacodynamics of tacrolimus in solid organ transplantation. Clin Pharmacokinet 43:623–53.
  • Venkataramanan R, Swaminathan A, Prasad T, et al. (1995). Clinical pharmacokinetics of tacrolimus. Clin Pharmacokinet 29:404–30.
  • Wang D, Chen X, Li Z. (2019a). Treatment of patients with systemic-onset juvenile idiopathic arthritis with tacrolimus. Exp Ther Med 17:2305–9.
  • Wang D, Chen X, Xu H, Li Z. (2019b). Population pharmacokinetics and dosing regimen optimisation of tacrolimus in Chinese pediatric hematopoietic stem cell transplantation patients. Xenobiotica. [Epub ahead of print]. doi:10.1080/00498254.2019.1601791
  • Wang DD, Chen X, Li ZP. (2018). Efficacy and safety of tacrolimus in treating pediatric refractory nephrotic syndrome: a meta-analysis. Int J Clin Exp Med 11:6436–44.
  • Wang DD, Chen X, Li ZP. (2019c). Population pharmacokinetics of sirolimus in pediatric patients with kaposiform hemangioendothelioma: a retrospective study. Oncol Lett 18:2412–19.
  • Wang DD, Chen X, Li ZP. (2019d). Wuzhi capsule and haemoglobin influence tacrolimus elimination in paediatric kidney transplantation patients in a population pharmacokinetics analysis: A retrospective study. J Clin Pharm Ther 44:611.
  • Yoshida T, Nakanishi K, Yoshioka T, et al. (2016). Oral tacrolimus oil formulations for enhanced lymphatic delivery and efficient inhibition of T-cell's interleukin-2 production. Eur J Pharm Biopharm 100:58–65.

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Order Reprints Request Corporate Permissions

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

Request Academic Permissions

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.

Related research

People also read lists articles that other readers of this article have read.

Recommended articles lists articles that we recommend and is powered by our AI driven recommendation engine.

Cited by lists all citing articles based on Crossref citations.
Articles with the Crossref icon will open in a new tab.